13 results on '"Joniau, S"'
Search Results
2. 174TiP SPARKLE: A new spark in treating oligorecurrent prostate cancer: Adding systemic treatment to stereotactic body radiotherapy or metastasectomy: Key to long-lasting event-free survival?
3. 1381P A transcriptomic signature of AR activity prognosticates development of castration-resistance following metastasis-directed therapy in oligometastatic castration-sensitive prostate cancer
4. Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†
5. 684P Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma
6. Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review
7. 693TiP LOBSTER LOng term Better than Short-TErm ADT with salvage radiotherapy
8. Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL
9. Multimodality treatment for pN1 prostate cancer: Adding elective para-aortic radiation in the PART trial
10. LBA56 - Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL
11. 861TiP - Multimodality treatment for pN1 prostate cancer: Adding elective para-aortic radiation in the PART trial
12. International Guidelines for the Definition of Time to Event Endpoints (Tee) in Renal Cell Cancer (Rcc) Randomised Clinical Trials (Rct): Results of the Datecan Project
13. 833P - International Guidelines for the Definition of Time to Event Endpoints (Tee) in Renal Cell Cancer (Rcc) Randomised Clinical Trials (Rct): Results of the Datecan Project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.